Abstract
Interleukin-25 (IL-25) plays a key role in the initiation and expansion of T helper (Th) 2 cell-mediated immune responses, thereby contributing to allergic diseases and host defense against helminthic parasites. More recent studies have however shown that IL-25 can also control the function of non-T cells, such as antigen presenting cells and endothelial cells, and reduces Th1/Th17-mediated pathologies. These new and exciting observations reveal a broader role for IL-25 than previously anticipated, and delineate various scenarios where therapeutic interventions around IL-25 activity can be imagined.
Keywords: IL-25, IBD, multiple sclerosis, diabetes, allergic diseases, Th cells, noxious agents, inflammatory bowel disease, TNF-, immunoglobulin E, inflammation, monoclonal antibodies, lymphoid tissue, immunity, nuocyte, Nippostrongylus brasiliensis, endotoxemia, preceding the development of overt disease, reduces the degree of CD4- and CD8-positive per-islet infi, RNA transcripts, atopic dermatitis, Crohn's disease, celiac disease, gluten-sensitive enteropathy
Current Molecular Medicine
Title: The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies
Volume: 11 Issue: 1
Author(s): R. Caruso, C. Stolfi, D. De Nitto, F. Pallone and G. Monteleone
Affiliation:
Keywords: IL-25, IBD, multiple sclerosis, diabetes, allergic diseases, Th cells, noxious agents, inflammatory bowel disease, TNF-, immunoglobulin E, inflammation, monoclonal antibodies, lymphoid tissue, immunity, nuocyte, Nippostrongylus brasiliensis, endotoxemia, preceding the development of overt disease, reduces the degree of CD4- and CD8-positive per-islet infi, RNA transcripts, atopic dermatitis, Crohn's disease, celiac disease, gluten-sensitive enteropathy
Abstract: Interleukin-25 (IL-25) plays a key role in the initiation and expansion of T helper (Th) 2 cell-mediated immune responses, thereby contributing to allergic diseases and host defense against helminthic parasites. More recent studies have however shown that IL-25 can also control the function of non-T cells, such as antigen presenting cells and endothelial cells, and reduces Th1/Th17-mediated pathologies. These new and exciting observations reveal a broader role for IL-25 than previously anticipated, and delineate various scenarios where therapeutic interventions around IL-25 activity can be imagined.
Export Options
About this article
Cite this article as:
Caruso R., Stolfi C., De Nitto D., Pallone F. and Monteleone G., The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies, Current Molecular Medicine 2011; 11 (1) . https://dx.doi.org/10.2174/156652411794474365
DOI https://dx.doi.org/10.2174/156652411794474365 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Natural Tregs in Systemic Lupus Erythematosus
Current Immunology Reviews (Discontinued) Editorial [Hot Topic: Anti-Neuroinflammatory Effects of Psychopharmaceuticals: Further than Monoamine Modulators (Guest Editor: Sadayuki Hashioka)]
Mini-Reviews in Medicinal Chemistry Anti-Inflammatory Properties of Drugs from saffron crocus
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Potential Role of the Endocannabinoid System in the Control of Multiple Scleorsis
Current Medicinal Chemistry - Central Nervous System Agents Mesenchymal Stem Cell-Based Therapy for the Treatment of Type 1 Diabetes Mellitus
Current Stem Cell Research & Therapy Nitric Oxide and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews Exogenous Progesterone: A Potential Therapeutic Candidate in CNS Injury and Neurodegeneration
Current Medicinal Chemistry PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders
Current Pharmaceutical Design Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research Anti-NMDA Receptor Encephalitis in Psychiatry
Current Psychiatry Reviews Ion Channels on Microglia: Therapeutic Targets for Neuroprotection
CNS & Neurological Disorders - Drug Targets Pixuvri<sup>®</sup> (Pixantrone Dimaleate, BBR 2778): From Lab to Market
Current Organic Chemistry Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Current Pharmaceutical Design Potential Application of Biliverdin Reductase and its Fragments to Modulate insulin/IGF-1/MAPK/PI3-K Signaling Pathways in Therapeutic Settings
Current Drug Targets Role of Free Radicals and Poly(ADP-Ribose)Polymerase-1 in the Development of Spinal Cord Injury: New Potential Therapeutic Targets
Current Medicinal Chemistry NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation
Current Immunology Reviews (Discontinued) Borna Disease Virus (BDV): Neuropharmacological Effects of a CNS Viral Infection
Current Neuropharmacology